Venus Medtech (Hangzhou) Inc. - Laporan Laba Rugi (TTM)

Venus Medtech (Hangzhou) Inc.
US ˙ OTCPK ˙ CNE100003PJ8

Laporan Laba Rugi (TTM)

Laporan Laba Rugi Venus Medtech (Hangzhou) Inc. menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 252 276 345 413 415 416 401 387 397 406 429 452 472 491 479 466 469 471 449 427
Change (%) 9.55 24.85 19.91 0.31 0.31 -3.52 -3.65 2.57 2.51 5.61 5.32 4.34 4.16 -2.53 -2.60 0.47 0.46 -4.63 -4.85
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 43 49 66 83 87 92 89 86 89 92 97 101 102 102 99 97 100 103 103 103
Change (%) 14.26 35.08 25.97 5.14 4.89 -2.95 -3.03 3.68 3.55 4.63 4.43 0.56 0.56 -2.64 -2.71 3.27 3.16 0.09 0.09
% of Revenue 16.94 17.67 19.11 20.08 21.05 22.01 22.14 22.28 22.52 22.75 22.54 22.35 21.54 20.79 20.77 20.74 21.32 21.89 22.98 24.17
Gross Operating Profit 209 227 279 330 327 324 312 300 307 314 333 351 370 389 379 370 369 368 346 324
Change (%) 8.59 22.66 18.47 -0.90 -0.91 -3.69 -3.83 2.26 2.21 5.90 5.57 5.43 5.15 -2.50 -2.57 -0.27 -0.27 -5.95 -6.33
% of Revenue 83.06 82.33 80.89 79.92 78.95 77.99 77.86 77.72 77.48 77.25 77.46 77.65 78.46 79.21 79.23 79.26 78.68 78.11 77.02 75.83
SG&A 247 239 267 295 320 345 364 382 410 437 468 500 476 453 435 416 404 392 366 340
Change (%) -3.45 11.84 10.59 8.38 7.74 5.49 5.20 7.09 6.62 7.23 6.74 -4.71 -4.94 -3.88 -4.36 -3.06 -2.81 -6.71 -7.20
% of Revenue 98.10 86.45 77.44 71.42 77.17 82.88 90.62 98.95 103.31 107.45 109.10 110.57 100.98 92.16 90.88 89.24 86.10 83.30 81.48 79.47
R&D 165 167 186 204 231 258 316 374 451 527 565 602 563 525 468 411 376 341 311 281
Change (%) 1.14 10.98 9.89 13.33 11.76 22.45 18.33 20.45 16.98 7.05 6.59 -6.39 -6.83 -10.85 -12.17 -8.50 -9.29 -8.78 -9.62
% of Revenue 65.63 60.59 53.85 49.36 55.76 62.12 78.84 96.84 113.71 129.77 131.53 133.12 119.43 106.83 97.71 88.11 80.25 72.46 69.31 65.83
OpEx 451 455 520 585 641 698 770 843 961 1,079 1,152 1,225 1,152 1,080 1,000 922 880 836 780 724
Change (%) 0.69 14.37 12.56 9.61 8.76 10.41 9.43 13.98 12.27 6.77 6.34 -5.91 -6.28 -7.35 -7.86 -4.59 -4.90 -6.72 -7.20
% of Revenue 179.18 164.68 150.86 141.62 154.74 167.77 192.00 218.06 242.31 265.38 268.29 270.90 244.28 219.78 208.90 197.62 187.67 177.65 173.76 169.48
Operating Income -200 -179 -175 -172 -227 -282 -369 -456 -564 -672 -722 -773 -681 -589 -522 -455 -411 -366 -331 -297
Change (%) -10.50 -1.84 -1.87 31.93 24.20 30.97 23.64 23.64 19.12 7.47 6.95 -11.91 -13.53 -11.38 -12.69 -9.77 -11.02 -9.41 -10.38
% of Revenue -79.18 -64.68 -50.86 -41.62 -54.74 -67.77 -92.00 -118.06 -142.31 -165.38 -168.29 -170.90 -144.27 -119.78 -108.90 -97.62 -87.67 -77.65 -73.76 -69.48
Interest Expense -2 -2 -1 -0 -1 -2 -11 -19 -32 -45 -51 -57 -60 -63 -52 -41 -29 -17 -15 -14
Change (%) 6.41 -48.40 -93.81 667.39 259.77 457.11 82.05 65.48 39.57 14.33 12.53 4.62 4.42 -17.05 -20.55 -29.86 -42.58 -7.91 -8.59
% of Revenue -0.81 -0.78 -0.32 -0.02 -0.13 -0.46 -2.65 -5.00 -8.06 -10.98 -11.88 -12.70 -12.73 -12.76 -10.86 -8.86 -6.19 -3.54 -3.41 -3.28
Net Income -210 -182 -217 -252 -313 -374 -417 -461 -759 -1,058 -1,133 -1,208 -956 -704 -632 -560 -637 -714 -678 -643
Change (%) -13.44 19.11 16.04 24.27 19.53 11.62 10.41 64.84 39.34 7.10 6.63 -20.87 -26.37 -10.21 -11.37 13.77 12.10 -5.02 -5.29
% of Revenue -83.44 -65.93 -62.89 -60.86 -75.40 -89.85 -103.95 -119.13 -191.45 -260.22 -263.89 -267.18 -202.62 -143.22 -131.94 -120.06 -135.96 -151.71 -151.09 -150.40

Source: Capital IQ

Other Listings
HK:2500 HK$ 4.22
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista